by Ryan Stancil
To say that it was a long time coming is an understatement, as is the fact that it’s still anyone’s guess what will really happen.
Still, the people who make the decisions are having this conversation.
In a memo released to lawmakers earlier this week, on page 5, the Drug Enforcement Agency (DEA) revealed that it is in the process of determining whether it will reclassify marijuana for the purposes of medical research. It hopes to make a decision in the first half of 2016.
At present, marijuana is a Schedule I drug, which means that it is defined as a drug with “no currently accepted medical use and a high potential for abuse.” It shares this classification with heroin and LSD, among others, and has been criminalized in the United States since the early 1900s.